Rinoprint® (Rhinopront®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceCarbinoxamine + PhenylephrineCarbinoxamine + Phenylephrine
Similar drugsTo uncover
  • Rinoprint®
    capsules inwards 
    MASK ENG, LLC     Russia
    • Dosage form: & nbspcapsules
    Pharmacotherapeutic group:antiallergic agent (H1-histamine receptor blocker + alpha-adrenomimetic)
    ATX: & nbsp

    R.01.A.B   Sympathomimetics in combination with other drugs (excluding corticosteroids)

    Form release / dosage:10 capsules in the blister pack.
    Packaging:1 blister in a cardboard box.
    Shelf life:5 years
    Terms of leave from pharmacies:Without recipe
    Registration number:P N014067 / 01-2002
    Date of registration:02.09.2009
    The owner of the registration certificate:MASK ENG, LLC MASK ENG, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp11.09.2012
    Illustrated instructions
      Instructions
      Up